| Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review A Desai, S Sandhu, JP Lai, DS Sandhu World journal of hepatology 11 (1), 1, 2019 | 256 | 2019 |
| Current trends in the management of gastroesophageal reflux disease DS Sandhu, R Fass Gut and liver 12 (1), 7, 2018 | 241 | 2018 |
| Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma JP Lai, DS Sandhu, C Yu, T Han, CD Moser, KK Jackson, RB Guerrero, ... Hepatology 47 (4), 1211-1222, 2008 | 236 | 2008 |
| Profile of breast cancer patients at a tertiary care hospital in north India DS Sandhu, S Sandhu, RK Karwasra, S Marwah Indian journal of cancer 47 (1), 16-22, 2010 | 211 | 2010 |
| Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review MH Cha, M Regueiro, DS Sandhu World journal of gastroenterology 26 (19), 2323, 2020 | 209 | 2020 |
| The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis JP Lai, DS Sandhu, AM Shire, LR Roberts Journal of gastrointestinal cancer 39, 149-158, 2008 | 119 | 2008 |
| Impact of COVID-19 on endoscopy trainees: an international survey KM Pawlak, J Kral, R Khan, S Amin, M Bilal, RN Lui, DS Sandhu, ... Gastrointestinal endoscopy 92 (4), 925-935, 2020 | 106 | 2020 |
| Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review S Chawla, A Katz, BM Attar, A Gupta, DS Sandhu, R Agarwal European journal of gastroenterology & hepatology 24 (4), 431-436, 2012 | 99 | 2012 |
| Fibroblast growth factor signaling in liver carcinogenesis DS Sandhu, E Baichoo, LR Roberts Hepatology 59 (3), 1166-1173, 2014 | 89 | 2014 |
| Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets DS Sandhu, AM Shire, LR Roberts Liver International 28 (1), 12-27, 2008 | 73 | 2008 |
| Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets JP Lai, JR Thompson, DS Sandhu, LR Roberts Future Medicine 4 (6), 803-814, 2008 | 62 | 2008 |
| Treatment options for hepatocellular carcinoma DS Sandhu, VS Tharayil, JP Lai, LR Roberts Expert Review of Gastroenterology & Hepatology 2 (1), 81-92, 2008 | 53 | 2008 |
| Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo JP Lai, DS Sandhu, CD Moser, SC Cazanave, AM Oseini, AM Shire, ... Journal of hepatology 50 (6), 1112-1121, 2009 | 52 | 2009 |
| Colorectal cancer, age, and obesity-related comorbidities: a large database study A Elangovan, J Skeans, M Landsman, SMJ Ali, AG Elangovan, ... Digestive diseases and sciences 66, 3156-3163, 2021 | 50 | 2021 |
| Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma AM Shire, DS Sandhu, JK Kaiya, AM Oseini, JD Yang, R Chaiteerakij, ... Mayo Clinic Proceedings 87 (1), 17-24, 2012 | 44 | 2012 |
| Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors JP Lai, DS Sandhu, C Yu, CD Moser, C Hu, AM Shire, I Aderca, ... Liver International 30 (10), 1522-1528, 2010 | 39 | 2010 |
| Diagnosis and management of cholangiocarcinoma DS Sandhu, LR Roberts Current gastroenterology reports 10 (1), 43-52, 2008 | 37 | 2008 |
| The impact of COVID-19 on gastrointestinal endoscopy training in the United Kingdom K Siau, M Iacucci, P Dunckley, I Penman, KM Pawlak, J Kral, R Khan, ... Gastroenterology 159 (4), 1582-1585. e3, 2020 | 35 | 2020 |
| COVID-19 and Canadian gastroenterology trainees R Khan, P Tandon, MA Scaffidi, K Bishay, KM Pawlak, J Kral, S Amin, ... Journal of the Canadian Association of Gastroenterology 4 (3), 156-162, 2021 | 15 | 2021 |
| Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease GS Kochhar, A Desai, F Caldera, S El Hachem, E Aoun, D Sandhu, ... Vaccine 39 (30), 4199-4202, 2021 | 14 | 2021 |
